Laura Sepp-Lorenzino is a director of Taysha Gene Therapies Inc.
Person profile
Roles
Address
Cambridge, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Intellia Therapeutics, Inc.
5 Mar 24
4
Intellia Therapeutics, Inc.
10 Jan 24
144
Intellia Therapeutics, Inc.
8 Jan 24
4
Intellia Therapeutics, Inc.
5 Jan 24
4
Intellia Therapeutics, Inc.
3 Jan 24
4
Taysha Gene Therapies, Inc.
26 Jun 23
4
Intellia Therapeutics, Inc.
3 Mar 23
4
Intellia Therapeutics, Inc.
6 Jan 23
4
Intellia Therapeutics, Inc.
4 Jan 23
4
Taysha Gene Therapies, Inc.
22 Jun 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Mar 24 | NTLA Intellia Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 37,966 | 0.00 | 81,893 |
1 Mar 24 | NTLA Intellia Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 32.66 | 54,794 | 1.79 mm | 54,794 |
8 Jan 24 | NTLA Intellia Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 29.38 | 667 | 19.60 k | 43,927 |
8 Jan 24 | NTLA Intellia Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 28.66 | 1,608 | 46.09 k | 44,594 |
3 Jan 24 | NTLA Intellia Therapeutics | Common Stock | Sell | Dispose S | No | No | 29.46 | 5,532 | 162.97 k | 46,202 |
1 Jan 24 | NTLA Intellia Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 3,500 | 0.00 | 51,734 |
1 Jan 24 | NTLA Intellia Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 3,500 | 0.00 | 3,500 |
22 Jun 23 | TSHA Taysha Gene Therapies | Stock Option Common Stock | Grant | Acquire A | No | No | 0.72 | 36,200 | 26.06 k | 36,200 |